Carroll Investors’s Albemarle ALB Stock Holding History

Carroll Investors’s Portfolio ALB Stock Details ALB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,993	Closed	-$682K	–	23
2023 Q3	$682K	Sell	3,993 -2,548	-39%	-$508K	0.6%	17
2023 Q2	$1.45M	Buy	6,541 +112	+2%	+$22.9K	1.09%	20
2023 Q1	$1.42M	Buy	6,429 +910	+16%	+$224K	1.16%	20
2022 Q4	$1.2M	Buy	5,519 +3,857	+232%	+$1.03M	1.27%	20
2022 Q3	$441K	Buy	+1,662	New	+$423K	0.36%	27

Other funds holding ALB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Carroll Investors's ALB Position: Q4 2023 in Review

Carroll Investors sold out of Albemarle (ALB) in Q4 2023, closing a stake of 3,993 shares — an estimated $682K sold.

Carroll Investors first reported a position in ALB in Q3 2022 and held it in 5 quarters. The position peaked at $1.45M in Q2 2023. 941 funds tracked by Wall St. Rank hold ALB as of Q4 2023.

Carroll Investors reported no remaining Albemarle position as of Q4 2023 after selling out during the quarter.
Carroll Investors sold 3,993 Albemarle shares in Q4 2023, an estimated $682K.
Carroll Investors first reported a position in Albemarle in Q3 2022 and held it in 5 quarters.
Carroll Investors's Albemarle position peaked at $1.45M in Q2 2023.
941 funds tracked by Wall St. Rank held Albemarle as of Q4 2023.

Based on Carroll Investors's 13F filing for Q4 2023, filed 14 Feb 2024.